| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/18/2008 | CN101200728A Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same |
| 06/18/2008 | CN101200720A Mitochondrial membrane potential decrease related polynucleotide as well as coded polypeptide and uses thereof |
| 06/18/2008 | CN101200709A Hybridoma cell line against akabane virus monoclonal antibody, monoclonal antibody as well as reagent kit and uses thereof |
| 06/18/2008 | CN101200708A Mouse anti-human CD14 monoclonal antibody hybridoma cell line, monoclonal antibody, immunohistochemical reagent kit and uses thereof |
| 06/18/2008 | CN101200502A Design of interferon-inducible protein-10 (IP10 or CXCL10) chemokine analogs for the treatment of human diseases |
| 06/18/2008 | CN100395331C High purity venom kininogenase prepartion method and its pharmaceutical formulation |
| 06/17/2008 | US7388088 isolated nucleic acid encoding a human antibody that specifically binds to C-ERBB-2 protein product of HER2/NEU oncogene; for diagnosis of cancer/tumors which over express this gene; for immunotoxins and other antitumor/anticarcinogenic agents; less immunogenic |
| 06/17/2008 | US7388086 NPHS2 gene involved in the steroid-resistant nephrotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
| 06/17/2008 | US7388080 Monoclonal antibody for use in treatment and prevention of pathogen infection |
| 06/17/2008 | US7388079 Delivery of pharmaceutical agents via the human insulin receptor |
| 06/17/2008 | US7388078 Nucleic acids encoding polypeptides having chips activity |
| 06/17/2008 | US7388074 Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereof |
| 06/17/2008 | US7388072 Melanoma Associated antigen (MAGE) tumor associated genes, nucleic acids encoding such peptides and antibodies relating thereto; Human Leukocyte Antigen (HLA) |
| 06/17/2008 | US7387900 Colloidal metal compositions and methods |
| 06/17/2008 | US7387897 Tetrameric antibody complexes for blocking non-specific labeling of antigens |
| 06/17/2008 | US7387895 peroxisome proliferator activated receptor |
| 06/17/2008 | US7387881 Marking using antigen; detecting cancer |
| 06/17/2008 | US7387873 Human myeloma cell line |
| 06/17/2008 | US7387779 Anti-angiogenic proteins and fragments and methods of use thereof |
| 06/17/2008 | US7387776 Human monoclonal antibodies against CD30 |
| 06/17/2008 | US7387772 or immunoreactive fragment thereof that binds to the Mu-9 epitope of a colon-specific antigen-p mucin (CSAp) antigen; binds target tissue and conjugate carrying epitope (haptens)l; immunoconjugate; fusion proteins; colon cancer |
| 06/17/2008 | CA2235468C Chaperone expression plasmids |
| 06/17/2008 | CA2187162C Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase iii (icerel iii) |
| 06/17/2008 | CA2183888C Antibody purification |
| 06/17/2008 | CA2117193C Vaccine comprising part of constant region of ige for treatment of ige-medicated allergic reactions |
| 06/17/2008 | CA2107463C Totipotent hematopoietic stem cell receptors and their ligands |
| 06/17/2008 | CA2067250C Inhibition of padgem-mediated cell binding |
| 06/17/2008 | CA1341575C Tumor necrosis factor (tnf) inhibitory protein and its purification |
| 06/17/2008 | CA1341574C Plasmid for production of membrane protein, bacterium containing same, monoclonal antibody therefore, and method for the idenification of haemophilus influenzae |
| 06/13/2008 | CA2598913A1 Incorporation of biomolecules in thin films |
| 06/12/2008 | WO2008070727A2 Recombinant antibodies against hepatitis c virus and methods of obtaining and using same |
| 06/12/2008 | WO2008070569A2 Human antibodies that bind cd22 and uses thereof |
| 06/12/2008 | WO2008070273A2 Methods of expressing lim mineralization protein |
| 06/12/2008 | WO2008070090A2 Compositions and methods for diagnosing and treating cancer |
| 06/12/2008 | WO2008069889A2 Methods of treating hemolytic anemia |
| 06/12/2008 | WO2008069122A1 Marker for differentiation of mesenchymal stem cell into chondrocyte |
| 06/12/2008 | WO2008068906A1 Diagnostic agent for mesothelioma, diagnosis kit for mesothelioma, and diagnosis method for mesothelioma |
| 06/12/2008 | WO2008068827A1 Kidney-specific novel organic ion transporter |
| 06/12/2008 | WO2008068752A2 Formation of organic nanostructure array |
| 06/12/2008 | WO2008068455A1 Protein purification |
| 06/12/2008 | WO2008068280A1 Peptides capable of binding to serum proteins |
| 06/12/2008 | WO2008068246A1 Liquid anti-rabies antibody formulations |
| 06/12/2008 | WO2008067651A1 Gender selection with the use of antibodies |
| 06/12/2008 | WO2008052030A3 A method for increasing antibody-dependent cytotoxicity with castanospermine |
| 06/12/2008 | WO2008048345A9 Detection systems for mass labels |
| 06/12/2008 | WO2008047134A3 Antibody molecules which bind il-17a and il-17f |
| 06/12/2008 | WO2008043146A9 Antibodies against non functional p2x7 receptor |
| 06/12/2008 | WO2008033473A3 Assay for the detection of phosphorylated pth |
| 06/12/2008 | WO2008032218A3 Diagnosis of hereditary spastic paraplegias (hsp) by detection of a mutation in the kiaa1840 gene or protein |
| 06/12/2008 | WO2008028686A3 Use of human cells of myeloid leukaemia origin for expression of antibodies |
| 06/12/2008 | WO2008025964A3 Antibodies to an epitope of agr2. assays and hybridomas |
| 06/12/2008 | WO2008020596A3 Treating or preventing cancers over-expressing reg4 or kiaa0101 |
| 06/12/2008 | WO2007143098A3 Hepatocyte growth factor (hgf) binding proteins |
| 06/12/2008 | WO2007117749A3 Il-17 antagonistic antibodies fpr treating cancer |
| 06/12/2008 | WO2007111964A3 Hepatitis c virus neutralizing antibodies |
| 06/12/2008 | WO2007087370A3 Tat-038 and methods of assessing and treating cancer |
| 06/12/2008 | WO2007051164A8 Toll like receptor 3 modulators, methods and uses |
| 06/12/2008 | US20080139815 Drug conjugates |
| 06/12/2008 | US20080139792 High Protein Concentration Formulations Containing Mannitol |
| 06/12/2008 | US20080139791 Non-antibody protein comprising domain having immunoglobulin-like fold, capable of binding to any compound; scaffold derived from fibronectin; optimal stability and solubility |
| 06/12/2008 | US20080139790 Antigen-binding portion comprising primate complementarity determining and framework region modified to reduce immunogenicity in humans; treating tumor necrosis factor disorders |
| 06/12/2008 | US20080139789 Isolated Broadly Reactive Opsonic Immunoglobulin for Treating a Pathogenic Coagulase-Negative Staphylococcus Infection |
| 06/12/2008 | US20080139783 Compositions and methods for detecting treponema pallidum |
| 06/12/2008 | US20080139479 Intelligent drug carrier capable of selective delivery; reduced side effects; isolated, labeled peptide of amino acid sequence 7; antibodies; kits |
| 06/12/2008 | US20080139477 Introduced DNA sequences are replicated, stably retained and segregated independent of continuous selection pressure |
| 06/12/2008 | US20080139476 Caspase-8 interacting proteins |
| 06/12/2008 | US20080139474 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 06/12/2008 | US20080139466 Dna Sequence and Expressed Recombinant Glycoproteins Related to Feline Thyrotropin |
| 06/12/2008 | US20080138914 Zeolite labeled with dye, stop-cock moiety, and affinity binding agent; visualized using magnetic resonance imaging and computed tomography |
| 06/12/2008 | US20080138899 Destroying cell expressing polypeptide of given sequence by contacting with cytotoxic immunoconjugate; ricin, doxorubicin; treatment and detection of prostate cancer metastasis |
| 06/12/2008 | US20080138898 Substituting amino acids in variable region framework sequence comprising heavy and light chains; higher yield |
| 06/12/2008 | US20080138897 Method for preventing HIV-1 infection of CD4+ Cells |
| 06/12/2008 | US20080138894 Recombinant expression in eukaryotic or mammalian cells using vectors; cleavage and site-directed mutagenesis |
| 06/12/2008 | US20080138860 Method For Improving Antibody |
| 06/12/2008 | US20080138855 Drug delivery; drug targetting |
| 06/12/2008 | US20080138840 Mycobacterium for use as source of immunoresponsive antigen; diagnosing microorganismal infection |
| 06/12/2008 | US20080138827 Glypican-3 (GPC3) specific immunoglobulin for use as evaluative tool in diagnsosing cell proliferative disorders |
| 06/12/2008 | US20080138825 Methods and compositions for selectively cleaving DNA containing duplex nucleic acids in a complex nucleic acid mixture, and nuclease compositions for use in practicing the same |
| 06/12/2008 | US20080138796 NRIF3, a novel co-activator for nuclear hormone receptors |
| 06/12/2008 | US20080138794 Method for detecting or measuring HBV |
| 06/12/2008 | US20080138365 Improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapy |
| 06/12/2008 | US20080138358 Protective protein comprising protease sequences from newly excysted juveniles for use in vaccination and prevention of parasitic infection of gut tissues |
| 06/12/2008 | US20080138356 Pili from Mycobacterium Tuberculosis |
| 06/12/2008 | US20080138352 Identification and characterization of novel proline racemases and hydroxyproline-2-epimerases, uses thereof, and methods of identifying proline racemases and hydroxyproline-2-epimerases |
| 06/12/2008 | US20080138349 Using variation in FC gamma receptor as therapeutic tool in treatment and prevention of infection, inflammatory, autoimmune and cell proliferative diseases |
| 06/12/2008 | US20080138348 G-protein coupled receptor ligands and methods |
| 06/12/2008 | US20080138347 Dsp-10 dual-specificity phosphatase |
| 06/12/2008 | US20080138346 Antibodies to a chemokine expressed in inflamed adenoid |
| 06/12/2008 | US20080138345 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 06/12/2008 | US20080138344 Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same |
| 06/12/2008 | US20080138343 Immunoglobulin for use in prevention and treatment of CD70 expressing cell proliferative disorders; immunosuppressant |
| 06/12/2008 | US20080138342 Using immunoglobulin specific to vascular endothelial growth factor receptor (Flt-1) as therapeutic tool in treatment toxemia in late pregnancy |
| 06/12/2008 | US20080138340 Methods and compositions for modulating the immune system of animals |
| 06/12/2008 | US20080138339 Anti human ovarian cancer-anti CD3 bispecific antibody |
| 06/12/2008 | US20080138338 Polypeptide variants |
| 06/12/2008 | US20080138336 Humanized Anti-CD19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease |
| 06/12/2008 | US20080138335 Stabilized Human IgG2 And IgG3 Antibodies |
| 06/12/2008 | US20080138334 Immune-Derived Moieties Reactive Against Bioactive Lipids, and Methods of Making and Using Same |
| 06/12/2008 | US20080138333 Internalizing anti-cd74 antibodies and methods of use |
| 06/12/2008 | US20080138332 Methods and Compositions for the Treatment and Prevention of Staphylococcus Aureus Infections Through Interference With OPUC Operon Interaction with TRAP |